中国女性早期乳腺癌患者维生素D缺乏管理专家共识(2023版)

Chinese Expert Consensus Recommendations for Management of Vitamin D Deficiency or Insufficiency in Female Patients with Early Breast Cancer(2023Edition)

乳腺癌患者维生素D的缺乏/不足广泛存在,严重影响患者的生活质量和预后。随着早期乳腺癌患者生存期不断延长,乳腺癌患者的维生素D缺乏/不足问题逐渐受到关注,但目前国内外仍缺乏针对早期乳腺癌患者维生素D缺乏/不足管理的指南或共识。中国抗癌协会肿瘤临床研究管理学专业委员会、重庆市临床医学研究联合会和重庆抗癌协会肿瘤内分泌专业委员会组织相关专家,基于国内外指南及循证医学证据,深入探讨并制定了《中国女性早期乳腺癌患者维生素D缺乏管理专家共识(2023年版)》,希望通过本共识规范早期乳腺癌患者维生素D缺乏/不足的管理。

Vitamin D deficiency or insufficiency in breast cancer patients is widespread and seriously af-fects the quality of life and prognosis of breast cancer patients.As the overall survival of early breast cancer women continues to increase,vitamin D deficiency or insufficiency is getting attention gradually.However,there is still a lack of targeted guidelines or consensus for the management of vitamin D deficiency or insufficiency in breast can-cer patients.Based on the guideline and the substantial evidence based medicine,the Society of Clinical Cancer Research Administration of China Anti-Cancer Association,Chongqing Federation of Clinical Medical Research,and the Society of Onco-Endocrinology of Chongqing Anti-Cancer Association thoroughly discussed and formulated the Chinese expert consensus recommendations for management of vitamin D deficiency or insufficiency in female patients with early breast cancer(version 2023),in order to further standardize the management of patient's vita-min D deficiency or insufficiency.